Business of Cannabis
Six live hubs. One source of truth. Trackers, original data, and editorial deep-dives across the moments shaping the global cannabis sector — deals, markets, policy, science, companies, and regulation.
Every announced deal in global cannabis — value, rationale, advisors — searchable by target, acquirer, and geography. Because consolidation is the story of this cycle.
Live prices, sector indices, and movers across U.S. MSOs, Canadian LPs, and European listings. One screen, no spreadsheet.
The defining U.S. policy story of the decade. DEA filings, congressional positions, and what Schedule III actually means for operators, investors, and patients — updated as it happens.
Peer-reviewed cannabis trials and outcomes, organised by indication, phase, and sponsor — the evidence base separating signal from noise.
Operators, suppliers, and service firms across the global supply chain — vetted listings with category, geography, and corporate hierarchy.
Country-by-country medical and adult-use frameworks across the EU-27 plus UK and Switzerland — what’s law, what’s pending, what’s enforced.
Independent journalism, original data, no paywalls.
All hubs & coverage →